MOTS-c

There are 45 papers on MOTS-c in aging research: 2 trials and 16 observational studies in people, 18 in animals, 1 in cells, 8 reviews. The newest story, Nov 1, 2026: “Peptide pretreatment blunts cell-based kidney repair in mice”.

Biomarker

45 papers study it68 more mention it44 findings

1 new paper in 30 daysSee all 113 papers on MOTS-c

At a glance

A human observational study links lower plasma MOTS-c with Alzheimer's disease and acute ischemic stroke; another links plasma levels with muscle quality in older men. Exercise trials report increases in muscle and circulating MOTS-c, but show no clear effect in healthy controls, women with PCOS, or Hispanic breast cancer survivors.

44 findings in 28 papers from 2018 to 2026, 1 of them since October 2026

“Post-exercise levels of MOTS-c among non-Hispanic White BCS were significantly associated with reductions in fat mass, body weight, HOMA-IR, CRP, and an increase in lean mass (p < 0.01).”
Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic White breast cancer survivorsScientific reports2021doi:10.1038/s41598-021-96419-z
  • Human trial2
  • Humans16
  • Animals18
  • Cells1

Interventions

11

Exercise

no changein humans2upin humans2upin mice2upin reviews1

6 studies
  1. Exercise showed no clear effect on MOTS-c in Hispanic breast cancer survivors.

    Human trialin Hispanic breast cancer survivors16 weeksn = 25

  2. Exercise increases MOTS-c in non-Hispanic White breast cancer survivors.

    Human trialin non-Hispanic White breast cancer survivors16 weeksn = 24

  3. Exercise increases MOTS-c in humans.

    Human trialskeletal muscle and circulation

  4. Exercise showed no clear effect on MOTS-c in healthy controls and women with PCOS.

    Human trialin healthy controls and women with PCOS8 weeks

  5. Exercise increases MOTS-c.

    Review

  6. Exercise increases MOTS-c in high-fat diet-induced obese mice.

    Animalsin high-fat diet-induced obese miceskeletal muscle

  7. Exercise increases MOTS-c in mice.

    Animalsin miceplasma and skeletal muscle

More on Exercise

Fasting

downin chickens1

1 study
  1. Fasting decreases MOTS-c in chickens (fasting).

    Animalsfastingheart

More on Fasting

Empagliflozin

upin humans1

1 study
  1. Empagliflozin is linked with higher MOTS-c in humans (type 2 diabetes, compared with insulin).

    Humanstype 2 diabetes, compared with insulin12 monthsn = 163

More on Empagliflozin

Endurance training

upin mice1

1 study
  1. Endurance training increases MOTS-c in mice.

    Animals

More on Endurance training

SGLT2 inhibitors

upin humans1

1 study
  1. SGLT2 inhibitors are linked with higher MOTS-c in diabetic patients with HFrEF.

    Humansin diabetic patients with HFrEFat least two monthsn = 74

More on SGLT2 inhibitors

Moderate-intensity interval training

upin P. obesus1

1 study
  1. Moderate-intensity interval training increases MOTS-c in diabetic sand rats.

    Animalsin diabetic sand rats8 weeksmalesn = 30

More on Moderate-intensity interval training

Voluntary running

upin rodent1

1 study
  1. Voluntary running increases MOTS-c in rodent (~1.5-5-fold).

    Animalsskeletal muscle4-8 weeks

More on Voluntary running

Endurance exercise

no changein humans1

1 study
  1. Endurance exercise was not clearly linked with MOTS-c in humans (professional athletes).

    Humansprofessional athletesserumhigh endurance compared with low/moderate endurance

More on Endurance exercise

Adiponectin

upin mice1

1 study
  1. Adiponectin increases MOTS-c in mice.

    Animalsin miceplasma and skeletal muscle

More on Adiponectin

Insulin

downin humans1

1 study
  1. Insulin decreases MOTS-c in humans during hyperinsulinemic-euglycaemic clamp following intralipid infusion (from 232 ± 124% to 165 ± 97% (NS) in control and from 349 ± 206% to 183 ± 177% (P < 0.05) in PCOS).

    Human trialduring hyperinsulinemic-euglycaemic clamp following intralipid infusion2 hours

More on Insulin

Intralipid

upin humans1

1 study
  1. Intralipid increases MOTS-c in controls and PCOS subjects (to 232 ± 124% of basal in control (P < 0.01) and to 349 ± 206% of basal in PCOS (P < 0.001)).

    Human trialin controls and PCOS subjects5 hours

More on Intralipid

Upstream

7

Obesity

no changein humans2

2 studies
  1. Obesity was not clearly linked with MOTS-c in humans (14.33 ± 3.76 pg/mL versus 13.67 ± 3.44 pg/mL, p = 0.395).

    Humansn = 85

  2. Obesity was not clearly linked with MOTS-c in humans (lean and obese humans) (0.48±0.16 vs 0.52±0.15 ng/mL, p=0.60).

    Humanslean and obese humans

More on Obesity

Acute lung injury

downin humans2

2 studies
  1. Acute lung injury is linked with lower MOTS-c in patients undergoing CPB.

    Humansin patients undergoing CPB

  2. Acute lung injury is linked with lower MOTS-c in humans after off-pump CABG.

    Humansafter off-pump CABG

More on Acute lung injury

Allergic asthma

downin humans1

1 study
  1. Allergic asthma is linked with lower MOTS-c in patients with asthma vs healthy volunteers.

    Humansin patients with asthma vs healthy volunteers

More on Allergic asthma

Traumatic brain injury

downin mice1

1 study
  1. Traumatic brain injury decreases MOTS-c in TBI mice.

    Animalsin TBI micebrainmales

More on Traumatic brain injury

Acute ischemic stroke

downin humans1

1 study
  1. Acute ischemic stroke is linked with lower MOTS-c in humans (compared to control) (p < 0.05).

    Humanscompared to controlplasma

More on Acute ischemic stroke

Alzheimer's disease

downin humans1

1 study
  1. Alzheimer's disease is linked with lower MOTS-c in humans (compared to control) (p < 0.05).

    Humanscompared to controlplasma

More on Alzheimer's disease

Obstructive sleep apnea

downin humans1

1 study
  1. Obstructive sleep apnea is linked with lower MOTS-c in humans (obstructive sleep apnea) (p < 0.000).

    Humansobstructive sleep apneaserumn = 90

More on Obstructive sleep apnea

Associations

18

Polyendocrine metabolic ovarian syndrome

downin humans1

1 study
  1. Polyendocrine metabolic ovarian syndrome is associated with MOTS-c in humans (compared with controls) (56% lower serum concentration versus controls).

    Reviewcompared with controlsserumfemales

More on Polyendocrine metabolic ovarian syndrome

Atherogenic index of plasma

upin silico1

1 study
  1. MOTS-c predicts atherogenic index of plasma in silico (diabetic individuals).

    In silicodiabetic individuals

More on Atherogenic index of plasma

Age

downin humans1

1 study
  1. Age predicts MOTS-c in humans.

    Humansn = 85

HOMA-IR

upin humans1

1 study
  1. MOTS-c is associated with HOMA-IR in humans (p < 0.05).

    Humansn = 85

More on HOMA-IR

Cellular senescence

downin animals1

1 study
  1. Cellular senescence is associated with MOTS-c with aging and senescence.

    Animalswith aging and senescencepancreatic islet

More on Cellular senescence

Type 2 diabetes

downin humans1

1 study
  1. Type 2 diabetes is associated with MOTS-c in humans (compared with healthy controls).

    Humanscompared with healthy controls

More on Type 2 diabetes

Muscle performance

upin humans1

1 study
  1. MOTS-c is associated with muscle performance in humans (chronic peritoneal dialysis).

    Humanschronic peritoneal dialysisn = 32

Aerobic exercise capacity

upin humans1

1 study
  1. MOTS-c is associated with aerobic exercise capacity in humans.

    Humans

Humanin

mixedin humans1

1 study
  1. Humanin is associated with MOTS-c in humans (correlation present in athletes but not sedentary controls).

    Humanscorrelation present in athletes but not sedentary controlsserum

More on Humanin

Endurance exercise

downin humans1

1 study
  1. Endurance exercise is associated with MOTS-c in humans (professional athletes compared with sedentary controls).

    Humansprofessional athletes compared with sedentary controlsserum

More on Endurance exercise

Body weight

downin humans1

1 study
  1. MOTS-c is associated with body weight in humans (post-exercise in non-Hispanic White breast cancer survivors).

    Human trialpost-exercise in non-Hispanic White breast cancer survivorsfemales

More on Body weight

All 18

Funding

1 grant since 2024

National Institute on Aging$1.6M

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 2Mar 2026: 1Apr 2026: 2May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 2Sep 2026: 0Oct 2026: 4Nov 2026: 016 papers in 12 months
Inflammation and Regeneration

Peptide pretreatment blunts cell-based kidney repair in mice

Groups of six mice received human stromal cells; peptide pretreatment failed to rescue repair by cells from donors with obesity and blunted benefits from donors without…Groups of six mice received human stromal cells; peptide pretreatment failed to rescue repair by cells from donors with obesity and blunted benefits from donors without obesity.

Mouse studyKidney

See all 113 papers on MOTS-c